INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

EVMNEvommune, Inc.

CIK 0002044725

EDGAR filingsOpen in network
Disclosed transactions38
Buys / sells2 / 3
Max Insider Score60
Connections9with evidence

EVMN · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
PC
Pena Luis C.Director, President & CEO
EVMNEvommune, Inc.
Grant or award
A$7,827
1,115 sh
Sep 30, 2026Oct 15, 2026
traded Sep 30, 2026
+15dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Pena Luis C.Director, President & CEO · Oct 15, 2026
  • ← Insider ofevidence
    Bauer EugeneDirector, Chief Medical Officer · Dec 19, 2025
  • ← Insider ofevidence
    LSP 7 Cooperative UA10% Owner · Nov 12, 2025
3
DS
Drew Janice SuzannChief of Dev. Operations
EVMNEvommune, Inc.
Option exercise · 10b5-1 plan
M
$15K
3,839 sh
Jun 22, 2026
Jun 24, 2026
traded Jun 22, 2026
+2d
SEC FORM 4

Evidence

0
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Option exercise · 10b5-1 plan
M—
1,488 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

6
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
1,488 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

11
DS
Drew Janice SuzannChief of Dev. Operations
EVMNEvommune, Inc.
Option exercise · 10b5-1 plan
M—
16.2K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

3
DS
Drew Janice SuzannChief of Dev. Operations
EVMNEvommune, Inc.
Option exercise · 10b5-1 plan
M—
3,839 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

24
DS
Drew Janice SuzannChief of Dev. Operations
EVMNEvommune, Inc.
Open-market sale · 10b5-1 plan
SELL$453K
20.0K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

7
DS
Drew Janice SuzannChief of Dev. Operations
EVMNEvommune, Inc.
Option exercise · 10b5-1 plan
M$48K
16.2K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

0
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Option exercise · 10b5-1 plan
M$5,714
1,488 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

19
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
16.7K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

10
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Option exercise · 10b5-1 plan
M$52K
13.5K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

11
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Option exercise · 10b5-1 plan
M—
13.5K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

9
DS
Drew Janice SuzannChief of Dev. Operations
EVMNEvommune, Inc.
Grant or award
A—
73.9K sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

9
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Grant or award
A—
69.3K sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

18
VI
Verduyn-van Weegen Felice IsabelDirector, 10% Owner
EVMNEvommune, Inc.
Grant or award
A$10.00M
358.7K sh
Feb 17, 2026Feb 18, 2026
traded Feb 17, 2026
+1dSEC FORM 4

Evidence

19
BE
Bauer EugeneDirector, Chief Medical Officer
EVMNEvommune, Inc.
Grant or award
A—
100.0K sh
Dec 8, 2025Dec 19, 2025
traded Dec 8, 2025
+11dSEC FORM 4

Evidence

20
MS
Moss Gregory S.Chief Business & Legal Officer
EVMNEvommune, Inc.
Tax withholding
F$243K
13.6K sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence

16
DS
Drew Janice SuzannEVP, Operations
EVMNEvommune, Inc.
Tax withholding
F$91K
5,074 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence

16
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Tax withholding
F$134K
7,513 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence

20
CK
Carver KyleChief Financial Officer
EVMNEvommune, Inc.
Tax withholding
F$237K
13.3K sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence

15
VI
Verduyn-van Weegen Felice IsabelDirector, 10% Owner
EVMNEvommune, Inc.
Derivative conversion
C—
6.59M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
VI
Verduyn-van Weegen Felice IsabelDirector, 10% Owner
EVMNEvommune, Inc.
Derivative conversion
C—
5.09M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
VI
Verduyn-van Weegen Felice IsabelDirector, 10% Owner
EVMNEvommune, Inc.
Derivative conversion
C—
15.49M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
VI
Verduyn-van Weegen Felice IsabelDirector, 10% Owner
EVMNEvommune, Inc.
Derivative conversion
C—
3.37M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

60
VI
Verduyn-van Weegen Felice IsabelDirector, 10% Owner
EVMNEvommune, Inc.
Open-market purchase
BUY$25.00M
1.56M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
DS
Drew Janice SuzannEVP, Operations
EVMNEvommune, Inc.
Derivative conversion
C—
12.5K sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
DS
Drew Janice SuzannEVP, Operations
EVMNEvommune, Inc.
Derivative conversion
C—
1,587 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Derivative conversion
C—
25.0K sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

19
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Derivative conversion
C—
3,175 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
LU
LSP 7 Cooperative UA10% Owner
EVMNEvommune, Inc.
Derivative conversion
C—
3.37M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
LU
LSP 7 Cooperative UA10% Owner
EVMNEvommune, Inc.
Derivative conversion
C—
6.59M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

60
LU
LSP 7 Cooperative UA10% Owner
EVMNEvommune, Inc.
Open-market purchase
BUY$25.00M
1.56M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
LU
LSP 7 Cooperative UA10% Owner
EVMNEvommune, Inc.
Derivative conversion
C—
5.09M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
LU
LSP 7 Cooperative UA10% Owner
EVMNEvommune, Inc.
Derivative conversion
C—
15.49M sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

9
MS
Moss Gregory S.Chief Business & Legal Officer
EVMNEvommune, Inc.
Grant or award
A—
293.5K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC FORM 4

Evidence

9
CK
Carver KyleChief Financial Officer
EVMNEvommune, Inc.
Grant or award
A—
279.4K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC FORM 4

Evidence

9
DS
Drew Janice SuzannEVP, Operations
EVMNEvommune, Inc.
Grant or award
A—
231.3K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC FORM 4

Evidence

9
PP
Patel Jeegar PravinkumarChief Scientific Officer
EVMNEvommune, Inc.
Grant or award
A—
179.6K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Verduyn-van Weegen Felice IsabelDirector, 10% Owner · Nov 12, 2025
  • ← Insider ofevidence
    Moss Gregory S.Chief Business & Legal Officer · Nov 7, 2025
  • ← Insider ofevidence
    Carver KyleChief Financial Officer · Nov 7, 2025
  • ← Insider ofevidence
    Patel Jeegar PravinkumarChief Scientific Officer · Nov 7, 2025
  • ← Insider ofevidence
    Drew Janice SuzannEVP, Operations · Nov 7, 2025